No Data
OncoTherapy Science: Extraordinary Report
MITSUBISHI ESTATE, 3Q operating profit increased by 32.5% to 194.4 billion yen.
MITSUBISHI ESTATE <8802> announced its financial results for the third quarter of the fiscal year ending March 2025, with operating revenue increasing by 13.1% year-on-year to 1 trillion 47.9 billion 19 million yen, and operating profit rising by 32.5% to 194.4 billion 78 million yen. Both income and capital gains are progressing smoothly towards the company's full-year financial estimates. In Japan, the stable Market Overview is being leveraged, leading to an increase in capital gains. Additionally, the Brokerage business is performing well. [Positive Evaluation] <8802> MITSUBISHI ESTATE Q4| <7740> TAMRON
OncoTherapy Science: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)
OncoTherapy Science 9-Mos Loss Y717.00M Vs Loss Y987.00M
Emerging Markets outlook: Attention may turn towards lightly traded ultra-low-priced stocks and biotech-related stocks.
■ Emerging Markets are left out of the investment choices. This week, Emerging Markets declined. During the same period, the Nikkei average fell by -1.95%, while the Growth Market Index fell by -2.67%, and the Growth Market 250 Index fell by -3.09%, indicating that Emerging Markets were relatively weaker. As attention turns to the central bank meetings in Japan and the United States, reports of Nissan <7201> and Honda <7267> beginning discussions on a management integration have redirected interest towards auto stocks and Auto Parts suppliers in the Main Board, leaving Emerging Markets out of the investment picture.
The Tokyo Stock Exchange Growth Index continues to decline, with lackluster price movements ahead of the Japan and US central bank meetings.
Tokyo Stock Exchange Growth Market Index 814.89 -2.43 / Volume 0.2 billion 14.75 million shares / Trading value 145.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 635.44 -2.83 / Volume 0.1 billion 5.09 million shares / Trading value 97.2 billion yen Today's growth market saw a continued decline in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, with 187 rising stocks, 363 declining stocks, and 45 unchanged. Today's growth market showed a soft trend. On the previous day, October 16 in the USA.